Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 10,659 | 1,137 | 9,448 |
| Samples | 734 | 144 | 583 |
| Peptides | 714 | 118 | 600 |
Function
DEPDC5 · DEP domain containing 5, GATOR1 subcomplex subunit
This gene encodes a member of the IML1 family of proteins involved in G-protein signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth by sensing the availability of nutrients. The protein encoded by this gene is a component of the GATOR1 (GAP activity toward Rags) complex which inhibits the amino acid-sensing branch of the mTORC1 pathway. Mutations in this gene are associated with autosomal dominant familial focal epilepsy with variable foci. A single nucleotide polymorphism in an intron of this gene has been associated with an increased risk of hepatocellular carcinoma in individuals with chronic hepatitis C virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014].
Isoforms & Proteins
21 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
| Transcript | UniProt | Mutations | Peptides |
|---|---|---|---|
| ENST00000382112 | O75140 | 707 | 559 |
| ENST00000645711 | O75140-9 | 699 | 551 |
| ENST00000433147 | H0Y770* | 693 | 547 |
| ENST00000645407 | A0A2R8Y7U0* | 692 | 545 |
| ENST00000400249 | O75140-4 | 691 | 544 |
| ENST00000644331 | O75140-4 | 691 | 544 |
| ENST00000400248 | O75140-1 | 690 | 543 |
| ENST00000642696 | O75140-1 | 690 | 543 |
| ENST00000382111 | O75140-5 | 673 | 529 |
| ENST00000645560 | A0A2R8Y6H3* | 664 | 521 |
| ENST00000646969 | A0A2R8Y6H3* | 664 | 521 |
| ENST00000535622 | O75140-8 | 656 | 514 |
| ENST00000646465 | A0A2R8Y721* | 638 | 506 |
| ENST00000651528 | O75140 | 535 | 400 |
| ENST00000642974 | A0A2R8Y7U6* | 306 | 251 |
| ENST00000400246 | A0A5F9UWT1* | 253 | 201 |
| ENST00000400242 | O75140-2 | 206 | 166 |
| ENST00000646755 | O75140-2 | 206 | 166 |
| ENST00000647438 | A0A2R8Y5P2* | 199 | 161 |
| ENST00000437411 | C9JGS4* | 53 | 41 |
| ENST00000645015 | C9JGS4* | 53 | 41 |
Gene Properties
Recurrent Mutations
All 559 amino-acid changes on canonical ENST00000382112 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in DEPDC5 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in DEPDC5 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| T-Lymphoblastic Leukemia | 7/40 18% | 0/0 0% |
| Endometrial Carcinoma | 15/42 36% | 37/612 6% |
| Glioblastoma | 4/98 4% | 0/0 0% |
| Chronic Myelogenous Leukemia | 1/25 4% | 0/0 0% |
| Colorectal Carcinoma | 30/143 21% | 91/3239 3% |
| Melanoma | 14/210 7% | 59/1899 3% |
| Squamous Cell Lung Carcinoma | 0/57 0% | 24/810 3% |
| Gastric Carcinoma | 7/74 9% | 42/1809 2% |
| Bladder Carcinoma | 1/58 2% | 25/956 3% |
| Non-Small Cell Lung Carcinoma | 14/304 5% | 28/1390 2% |
| Oral Cavity Carcinoma | 1/54 2% | 0/0 0% |
| Cervical Carcinoma | 1/35 3% | 7/422 2% |
| Other Solid Cancers | 0/94 0% | 27/1515 2% |
| Ewings Sarcoma | 3/63 5% | 2/262 1% |
| Small Cell Lung Carcinoma | 0/9 0% | 11/752 1% |
| Hodgkins Lymphoma | 1/16 6% | 1/122 1% |
| Pheochromocytoma and Paraganglioma | 0/0 0% | 1/71 1% |
| Neuroendocrine Tumour | 3/154 2% | 7/577 1% |
| Ovarian Carcinoma | 6/109 6% | 9/998 1% |
| Thyroid Gland Carcinoma | 2/45 4% | 20/1592 1% |
| Head and Neck Carcinoma | 3/85 4% | 19/1574 1% |
| Biliary Tract Carcinoma | 2/54 4% | 11/950 1% |
| Hepatocellular Carcinoma | 1/46 2% | 27/2210 1% |
| Glioma | 0/52 0% | 27/2127 1% |
| Germ Cell Tumour | 0/25 0% | 2/169 1% |
| Esophageal Carcinoma | 1/23 4% | 7/769 1% |
| Esophageal Squamous Cell Carcinoma | 2/51 4% | 23/2550 1% |
| Osteosarcoma | 2/45 4% | 0/166 0% |
| Other Sarcomas | 3/69 4% | 4/699 1% |
| Breast Carcinoma | 4/144 3% | 25/3264 1% |
Mutation Distribution
Where DEPDC5 is mutated · all tissues, split by cell line vs tissue
How many mutations in DEPDC5 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 54 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 10,659 mutations in DEPDC5
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|